Literature DB >> 16369705

Prognostic factors for sporadic medullary thyroid carcinoma.

Kaptan Gülben1, Uğur Berberoğlu, Mustafa Boyabatli.   

Abstract

INTRODUCTION: Medullary thyroid carcinoma (MTC) originates from the thyroid parafollicular cells and accounts for 3% to 10% of all thyroid malignancies. Approximately 84% of cases are sporadic. The aim of this study was to evaluate the outcomes of treatment for sporadic medullary thyroid carcinoma (SMTC) and define the prognostic factors for overall survival.
METHODS: The records of 32 SMTC patients treated at Ankara Oncology Education and Research Hospital between September 1993 and April 2003 were retrospectively evaluated. The effects of age, gender, tumor localization, extent of the primary surgical resection, tumor size, capsule invasion, lymph node metastasis, extranodal extension, tumor stage, local recurrence, and distant metastasis on the overall survival rate were evaluated by univariate and multivariate analyses.
RESULTS: There were 32 patients (19 females, 13 males) with a median age of 45 years (21-76 years). Altogether, 22 patients had undergone complete resection and 10 patients incomplete resection. The median follow-up was 48 months (9-111 months), and the overall 5-year survival rate was 51%. Based on the univariate analysis, the extent of primary surgical resection, pathologic tumor size, capsule invasion, lymph node invasion, extranodal extension, tumor stage, local recurrence, and distant metastasis were factors that significantly affected survival. In the multivariate analysis, however, only the extent of the primary surgical resection, capsule invasion, and distant metastasis were found to be statistically significant factors.
CONCLUSIONS: The extent of the primary surgical resection significantly influences the survival of patients with SMTC. Capsule invasion and distant metastasis were additional factors affecting the prognosis.

Entities:  

Mesh:

Year:  2006        PMID: 16369705     DOI: 10.1007/s00268-005-7949-z

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  39 in total

1.  Management of medullary carcinoma of the thyroid.

Authors:  W J Simpson; J A Palmer; I B Rosen; R A Mustard
Journal:  Am J Surg       Date:  1982-10       Impact factor: 2.565

2.  Clinicopathologic and flow cytometric DNA study of medullary thyroid carcinoma.

Authors:  A K el-Naggar; N G Ordonez; D McLemore; P Schultz; R C Hickey; N Samaan
Journal:  Surgery       Date:  1990-12       Impact factor: 3.982

3.  Significance of nondiagnostic fine-needle aspiration of the thyroid.

Authors:  T Schmidt; M W Riggs; V O Speights
Journal:  South Med J       Date:  1997-12       Impact factor: 0.954

4.  Medullary thyroid cancer: the role of radiotherapy in local control.

Authors:  K M Fife; M Bower; C L Harmer
Journal:  Eur J Surg Oncol       Date:  1996-12       Impact factor: 4.424

5.  Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991.

Authors:  F D Gilliland; W C Hunt; D M Morris; C R Key
Journal:  Cancer       Date:  1997-02-01       Impact factor: 6.860

6.  Multivariate analysis of prognostic factors in sporadic medullary carcinoma of the thyroid. A retrospective study of 109 consecutive patients.

Authors:  L Scopsi; G Sampietro; P Boracchi; R Del Bo; M Gullo; M Placucci; S Pilotti
Journal:  Cancer       Date:  1996-11-15       Impact factor: 6.860

7.  Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German Medullary Thyroid Carcinoma Register.

Authors:  F Raue; J Kotzerke; D Reinwein; S Schröder; H D Röher; H Deckart; R Höfer; M Ritter; F Seif; H Buhr
Journal:  Clin Investig       Date:  1993-01

8.  Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

Authors:  L M Mulligan; J B Kwok; C S Healey; M J Elsdon; C Eng; E Gardner; D R Love; S E Mole; J K Moore; L Papi
Journal:  Nature       Date:  1993-06-03       Impact factor: 49.962

9.  Medullary carcinoma of thyroid. Biologic behavior of the sporadic and familial neoplasm.

Authors:  K Kakudo; J A Carney; G W Sizemore
Journal:  Cancer       Date:  1985-06-15       Impact factor: 6.860

10.  Medullary thyroid carcinoma: prognostic factors and treatment.

Authors:  P Rougier; C Parmentier; A Laplanche; M Lefevre; J P Travagli; B Caillou; M Schlumberger; J Lacour; M Tubiana
Journal:  Int J Radiat Oncol Biol Phys       Date:  1983-02       Impact factor: 7.038

View more
  15 in total

1.  Long-term outcome of reoperations for medullary thyroid carcinoma.

Authors:  Elizabeth Fialkowski; Mary DeBenedetti; Jeffrey Moley
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

2.  Long-Term Outcome After Surgery for Medullary Thyroid Carcinoma: A Single-Center Experience.

Authors:  Francesca Torresan; Elisabetta Cavedon; Caterina Mian; Maurizio Iacobone
Journal:  World J Surg       Date:  2018-02       Impact factor: 3.352

3.  Predictive factors that influence the course of medullary thyroid carcinoma.

Authors:  Kalliopi Pazaitou-Panayiotou; Alexandra Chrisoulidou; Stylianos Mandanas; Konstantinos Tziomalos; Eleni Doumala; Frideriki Patakiouta
Journal:  Int J Clin Oncol       Date:  2013-07-06       Impact factor: 3.402

4.  Results of Surgical Therapy in Patients with Medullary Thyroid Carcinoma.

Authors:  Mihaela Vlad; Ioana Zosin; Bogdan Timar; Fulger Lazar; Adrian Vlad; Romulus Timar; Marioara Cornianu
Journal:  Indian J Surg       Date:  2015-11-12       Impact factor: 0.656

5.  Excellent prognosis of patients with nonhereditary medullary thyroid carcinoma with ultrasonographic findings of follicular tumor or benign nodule.

Authors:  Mitsuhiro Fukushima; Yasuhiro Ito; Mitsuyoshi Hirokawa; Akihiro Miya; Kaoru Kobayashi; Haruki Akasu; Kazuo Shimizu; Akira Miyauchi
Journal:  World J Surg       Date:  2009-05       Impact factor: 3.352

6.  Alternative surgical strategies and favorable outcomes in patients with medullary thyroid carcinoma in Japan: experience of a single institution.

Authors:  Yasuhiro Ito; Akira Miyauchi; Tomonori Yabuta; Mitsuhiro Fukushima; Hiroyuki Inoue; Chisato Tomoda; Takashi Uruno; Minoru Kihara; Takuya Higashiyama; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka
Journal:  World J Surg       Date:  2009-01       Impact factor: 3.352

7.  Multifocality in Sporadic Medullary Thyroid Carcinoma: An International Multicenter Study.

Authors:  Garth F Essig; Kyle Porter; David Schneider; Debora Arpaia; Susan C Lindsey; Giulia Busonero; Daniel Fineberg; Barbara Fruci; Kristien Boelaert; Johannes W Smit; Johannes Arnoldus Anthonius Meijer; Leonidas H Duntas; Neil Sharma; Giuseppe Costante; Sebastiano Filetti; Rebecca S Sippel; Bernadette Biondi; Duncan J Topliss; Furio Pacini; Rui M B Maciel; Patrick C Walz; Richard T Kloos
Journal:  Thyroid       Date:  2016-10-11       Impact factor: 6.568

8.  Medullary Thyroid Cancer: It is a pain in the neck?

Authors:  Marlon A Guerrero; Sheila Lindsay; Insoo Suh; Menno R Vriens; Elham Khanafshar; Wen T Shen; Jessica Gosnell; Electron Kebebew; Quan-Yang Duh; Orlo H Clark
Journal:  J Cancer       Date:  2011-04-08       Impact factor: 4.207

9.  One-step nucleic acid amplification testing in medullary thyroid cancer lymph nodes: a case series.

Authors:  Krzysztof Kaczka; Wojciech Fendler; Maciej Borowiec; Wojciech Młynarski; Katarzyna Paduszynska; Anna Grzegory; Lech Pomorski
Journal:  Arch Med Sci       Date:  2015-03-14       Impact factor: 3.318

10.  Sporadic medullary thyroid carcinoma: clinical data from a university hospital.

Authors:  Joya Emilie M Correia-Deur; Rodrigo A Toledo; Alice T Imazawa; Delmar M Lourenço; Marilza C L Ezabella; Marcos R Tavares; Sergio P A Toledo
Journal:  Clinics (Sao Paulo)       Date:  2009-05       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.